SOPHiA GENETICS Announces Filing of Registration Statement for Proposed Initial Public Offering

BOSTON and LAUSANNE, Switzerland, July 2, 2021 — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. SOPHiA GENETICS SA has applied to list its ordinary shares on The Nasdaq Global Select Market under the symbol “SOPH.”

 

READ MORE